The United States represents the largest contributor to the Injection Pen Market in North America, driven by the rising prevalence of chronic diseases such as diabetes, autoimmune disorders, growth hormone deficiencies, and osteoporosis. The country’s advanced healthcare infrastructure, high healthcare spending, and strong adoption of self-administration therapies have significantly...